Fate Therapeutics Inc (FATE)

Last Year

25-Apr-23 -- 24-Apr-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

5

(1)

25

0

0

+1

0

+2

0

+3

Two Year Chart

25-Apr-22 -- 24-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
10-Jan-24 4:29 PM View:	09-Jan-24 Sale ($62.89K)	Wolchko J Scott President and CEO Director		Fate Therapeutics Inc - FATE	(4%) 385.64K to 371.25K	0	0	--	--	Show Txns Hide Txns

28-Dec-23 9:30 PM View:	26-Dec-23 Disposition (other) $6.16M	Redmile Group, LLC Director 10% Owner		Fate Therapeutics Inc - FATE	0% 13.14M to 13.18M	0	0	--	--	Show Txns Hide Txns

05-Mar-24 4:24 PM View:	04-Mar-24 Sale (Planned) ($19.01K)	Dulac Edward J III Chief Financial Officer		Fate Therapeutics Inc - FATE	(22%) 129.47K to 101.48K	0	0	--	--	Show Txns Hide Txns

07-Aug-23 4:01 PM View:	04-Aug-23 Sale (Planned) ($2.34K)	Xu Yuan Director		Fate Therapeutics Inc - FATE	(31%) 13.39K to 9.3K	0	0	--	--	Show Txns Hide Txns

10-Jan-24 4:30 PM View:	09-Jan-24 Sale ($49.37K)	Valamehr Bahram Chief R&D Officer		Fate Therapeutics Inc - FATE	(7%) 169.34K to 158.07K	0	0	--	--	Show Txns Hide Txns

10-Jan-24 4:30 PM View:	09-Jan-24 Sale ($47.52K)	Tahl Cindy General Counsel and Secretary		Fate Therapeutics Inc - FATE	(20%) 177.6K to 142.36K	0	0	--	--	Show Txns Hide Txns

06-Jul-23 5:19 PM View:	05-Jul-23 Sale ($18.77K)	Powl Brian T. Chief Commercial Officer		Fate Therapeutics Inc - FATE	(9%) 45.0K to 41.15K	0	0	--	--	Show Txns Hide Txns